BIG1 — Bio-Gate AG Share News
0.000.00%
Last trade - 00:00- €6.01m
- €5.84m
- €7.05m
Brief: Bio-Gate FY Net Result Loss Narrows To EUR 0.55 Mln
Brief: Bio Gate H1 Group Loss Narrows At EUR -68,000
Brief: Bio Gate Cooperates With Avicanna To Enter CBD Market
Brief: Bio Gate Completes Cash Capital Increase
Brief: Bio Gate Decides On Cash Capital Increase
Brief: Bio Gate Successfully Markets Antiviral And Antibacterial Protective Film Spray
Brief: Bio Gate H1 Sales Up At EUR 2.43 Mln
Brief: Bio Gate Partners With Aesculap For Implant Coating
Brief: Bio Gate FY Loss Widens To EUR 1.0 Million
Brief: Bio Gate To Place Capital Increase
Brief: Bio Gate Says Screening Test Confirms Effectiveness Of Various MicroSilver BGTM Products Against Viruses
Brief: Bio Gate Concludes Framework Agreement For Implant Coatings In Human Medicine
Brief: Bio Gate Adjusts Sales And Earnings Forecast For 2019
Brief: Bio Gate Cuts EBITDA Forecast, Confirms Sales And Net Profit Targets For 2019
Brief: Bio Gate Signs Contract With Implant Manufacturer
Brief: Bio Gate FY Group Loss Widens To Around EUR 0.9 Mln
Brief: Bio Gate Resolves And Places Cash Capital Increase
Brief: Bio Gate AG Expands Its Veterinary Business And Opens Up New Markets
Brief: Bio Gate Completes FDA Pre-Submission Application For HyProtect Coating Technology